 Please visit our Research Area of the Month page (Hematological Cancers) and see how Novus' large catalog of products can accelerate your research. Novus has antibodies to multiple aspects of hematopoietic and lymphoid malignancies, including: |
|
Please visit our Research Area of the Month page (Hematological Cancers) and see how Novus' large catalog of products can accelerate your research. Novus has antibodies to multiple aspects of hematopoietic and lymphoid malignancies, including: |
 Cardiac hypertrophy is a response of the heart to adapt to increased work load, featured with an increased size of cardiomyocytes, enhanced protein synthesis and a higher organization of the sarcomere. Initially beneficial, cardiac hypertrophy is triggered by various endocrine, paracrine, and autocrine growth factors in response to biomechanical stress, increased workload, injury, or intrinsic defects in contractile performance, but a sustained cardiac hypertrophy can lead to decompensation and... |
 With the recent "Ice Bucket Challenge" expanding awareness for Amyotrophic Lateral Sclerosis (ALS), Novus Biologicals would like to extend a 10% offer to researchers on the purchase of one antibody through October 1st 2014. |
|
New Blue Marker Antibody allows you to view protein standards and your target of interest together on the same blot, with the same exposure! Our Anti-Blue Antibody is available in unconjugated (NBP2-33376) and HRP-conjugated (NBP2-33376H) formats.
|
Cell cycle is a series of events that occur in a cell leading to its division and replication. Cell cycle checkpoints monitor cell cycle progression at specific points to allow the verification of necessary phase processes and repair of DNA damages. Loss of cell cycle checkpoints has been considered the most universal alteration in human cancer. While the cell cycle progression is driven by the cyclin-dependent kinases (CDKs) and their regulatory partners the cyclins, cell... |